Epigallocatechin-3-gallate Modulates MicroRNA Expression Profiles in Human Nasopharyngeal Carcinoma CNE2 Cells.

Bin-Bin LI; Guo-Liang HUANG; Hua-Hui LI; Xia KONG; Zhi-Wei HE

Return

Epigallocatechin-3-gallate Modulates MicroRNA Expression Profiles in Human Nasopharyngeal Carcinoma CNE2 Cells.

Author: Bin-Bin LI ¹ ; Guo-Liang HUANG ² ; Hua-Hui LI ² ; Xia KONG ³ ; Zhi-Wei HE ⁴ ;
Author Information

1. Department of Pathophysiology, Guangdong Medical University, Dongguan, Guangdong 523808; Sino-American Cancer Research Institute, Key Laboratory for Medical Diagnostics of Guangdong Province, Guangdong Medical University, Dongguan, Guangdong 523808, China.
2. Sino-American Cancer Research Institute, Key Laboratory for Medical Diagnostics of Guangdong Province, Guangdong Medical University, Dongguan, Guangdong 523808, China.
3. Department of Pathophysiology, Guangdong Medical University, Dongguan, Guangdong 523808, China.
4. Department of Pathophysiology, Guangdong Medical University, Dongguan, Guangdong 523808
Publication Type:Journal Article
MeSH: Antineoplastic Agents; pharmacology; Carcinoma; Catechin; analogs & derivatives; pharmacology; Cell Line, Tumor; Computational Biology; Gene Expression; drug effects; genetics; Humans; MicroRNAs; genetics; metabolism; Nasopharyngeal Neoplasms; genetics; Real-Time Polymerase Chain Reaction; Signal Transduction; drug effects; genetics
From: Chinese Medical Journal 2017;130(1):93-99
CountryChina
Language:English
Abstract:
BACKGROUNDEpigallocatechin-3-gallate (EGCG) has exhibited antitumor properties in several types of cancers, including nasopharyngeal carcinoma (NPC), but the molecular mechanisms underlying this function remain incompletely understood. The aim of the present study was to characterize the global impact of EGCG on the expression of microRNAs (miRNAs) in NPC cells.
METHODSUsing microarray analysis, the alterations of miRNA expression profiles were investigated in EGCG-treated CNE2 cells. Furthermore, the target genes and signaling pathways regulated by EGCG-specific miRNAs were identified using target prediction program and gene ontology analysis.
RESULTSA total of 14 miRNAs exhibited >2-fold expression changes in a dose-dependent manner after treatment with 20 μmol/L and 40 μmol/L EGCG. Totally 43, 49, and 52 target genes from these differentially expressed miRNAs were associated with the apoptosis, cell cycle regulation, and cell proliferation, respectively. A total of 66 signaling pathways, primarily involved in cancer development and lipid and glucose metabolism, were shown to be regulated by EGCG-specific miRNAs.
CONCLUSIONEGCG induces considerable alterations of miRNA expression profiles in CNE2 cells, which provides mechanistic insights into cellular responses and antitumor activity mediated by EGCG.